MedPath

The effect of N-acetylcysteine and ascorbic acid on pulmonary arterial pressure and ventilation during normoxia, hypoxia and hyperoxia and total oxidant capacity.

Completed
Conditions
acute mountain sickness
COPD
10037454
Registration Number
NL-OMON33919
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
14
Inclusion Criteria

That the volunteer is healthy

Exclusion Criteria

Exclusion criteria are:
• Obesity (BMI > 30)
• Presence of medical disease: heart-, lung-, liver-, kidney- and lung disease; diabetes
• Presence of psychiatric disease
• History of chronic alcohol or drug use
• Possibility of pregnancy
• Lactation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>pulmonal arterial pressure<br /><br>total oxidant capacity<br /><br>The ventilation will be analyzed on-line and is visible on-screen using custom<br /><br>made software (ACQ and RESREG developed by Erik Olofsen and Erik Kruyt,<br /><br>respectively). The breathing data will be collected on disc on a<br /><br>breath-to-breath basis for further analysis.zie protocol pagina 6 data steering</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>none</p><br>
© Copyright 2025. All Rights Reserved by MedPath